Stock 20B BIOMARK DIAGNOSTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Biomark Diagnostics Inc.

Equities

20B

CA09073K1084

Market Closed - Deutsche Boerse AG
Other stock markets
 02:03:07 2024-05-21 EDT 		5-day change 1st Jan Change
0.137 EUR -0.72% Intraday chart for Biomark Diagnostics Inc. -3.52% -6.80%
02-29 Biomark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
02-28 BioMark Diagnostics Inc. Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Biomark Diagnostics : Announces Warrant Extension and Granting of Options
PU
BioMark Announces Warrant Extension and Granting of Options
NE
BioMark to Advance Development of Cancer Treatment for Glioblastoma
NE
Biomark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
BioMark Diagnostics Inc. Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities
CI
BioMark Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities
NE
Biomark Diagnostics Inc. Appoints Theresa Peterson as Member of Advisory Team
CI
Theresa Peterson Joins Biomark's Advisory Team
NE
Biomark Diagnostics Closes $1.9 Million Non-Brokered Private Placement
MT
BioMark Announces Closing of $1.9 Million Non-Brokered Private Placement
NE
Biomark Diagnostics Inc. announced that it has received CAD 1.9 million in funding
CI
BioMark Announces New Patent Granted in Canada For Liquid Biopsy Based Legacy Assay
MT
BioMark Announces Recent New Patent Granted in Canada to Support Its Liquid Biopsy Based Legacy Assay
NE
BioMark Provides Second Quarter Operational Update and Announces Extension to Warrant Exercise Term
NE
Biomark Diagnostics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
BioMark Diagnostics Inc. Appoints Randolph Ford to its Strategic Advisory Team
CI
BioMark Strengthens and Expands Its Strategic Advisory Team in Pursuit of Commercialization Initiatives
NE
BioMark Announces Financial Contribution from the City of Quebec to Support Commercialization Initiatives of Its Proprietary Lung Cancer Detection Test
NE
BioMark to Unveil Results of Its Early Breast Cancer Study at the Upcoming San Antonio Breast Cancer Symposium
NE
Biomark Diagnostics : Une Technologie d’ici Pour Mieux Diagnostiquer le Cancer du Poumon – Local Technology for Improved Lung Cancer Diagnosis
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 20B Stock
  4. News Biomark Diagnostics Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW